Open access · OA
via Europe PMC
Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers.
Cai G, Ren J, Wang L, Wu Y, Wang H, Cao X, Shang H, Hou X, Wang Y, Xue H, Dong T.
MedComm · 2026
Genomic instability
Epigenetic alterations
Cellular senescence
Chronic inflammation
Senolytics
Human
Review
Abstract
Cellular senescence(definition), a stress-induced, irreversible cell cycle arrest coupled with a proinflammatory secretory phenotype, has emerged as both a central driver of aging and a tractable therapeutic target. Although acute senescence contributes beneficially to tumor suppression and wound healing, chronic accumulation of senescent cells sustains systemic inflammaging(definition) and accelerates organ dysfunction. This review synthesizes current progress in aging biology into a unified mechanistic and translational framework. We first examine how primary aging hallmarks, such as genomic instability and epigenetic dysregulation, interact to trigger cellular senescence, then explore how these converging molecular processes give rise to distinct age-related pathologies across reproductive, pulmonary, hepatic, neurological, skeletal, and metabolic systems. We further evaluate emerging interventional strategies, from senolytics(definition) and senomorphics to rejuvenation approaches, while addressing key translational barriers including targeting specificity, senescence heterogeneity, and equitable access. By uniting mechanistic insight with disease-oriented and therapeutic perspectives, this review charts a strategic roadmap for deploying senescence-targeting therapies to extend human healthspan(definition).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/mco2.70827
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
G, C., J, R., L, W., Y, W., H, W., X, C., H, S., X, H., Y, W., H, X., & T., D. (2026). Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers. <em>MedComm</em>. https://doi.org/10.1002/mco2.70827
Vancouver
G C, J R, L W, Y W, H W, X C, et al. Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers. MedComm. 2026. doi:10.1002/mco2.70827.
BibTeX
@article{cai2026Cellul,
title = {Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers.},
author = {Cai G and Ren J and Wang L and Wu Y and Wang H and Cao X and Shang H and Hou X and Wang Y and Xue H and Dong T.},
journal = {MedComm},
year = {2026},
doi = {10.1002/mco2.70827},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2026
Preprint
Molecular and Cellular Mechanisms of Aging: An Integrative Update on the Hallmarks, Emerging Regulators, and Translational Frontiers
Biomolecules 2025
Open access · CC-BY
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
Pharmaceuticals 2025
Open access · CC-BY
Cellular Senescence in Health, Disease, and Lens Aging
MedComm 2024
Open access · CC-BY
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Biogerontology 2026
Citation only
Senescent cells in systemic aging: SASP heterogeneity, immune escape, and endocrine modulation.
Journal of Advanced Biological Sciences 2026
Open access · CC-BY